By Diana Novak Jones (Reuters) -A federal judge has rejected a bid by compounding pharmacies to allow them to continue making ...

Health policy experts say the tariffs would raise prices for patients, potentially disrupt supply, and could hurt the US ...

Futures contracts, particularly due to their prevalence in other industries, have working case studies that highlight the ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to ...

The ruling is a blow to compounding pharmacies that had been allowed to produce hundreds of thousands of doses of copies of obesity drugs while the FDA said there was a shortage of them.

Four U.S. senators have reintroduced a bipartisan bill focused on strengthening the pharmaceutical supply chain by ...

The judge said that the FDA had appropriately weighed supply and demand data for the drugs and properly removed them from the ...

Argentina’s President Javier Milei, a fan of US President Donald Trump, has crushed the country’s public healthcare with ...

Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website ...

APPs are increasingly integral to healthcare delivery, and include nurse practitioners (NPs), physician assistants (PAs), ...

TradeWinds is the essential source of global shipping business news and commentary. Our subscription service offers the ...